临床医学工程2024，Vol.31Issue(7)：857-858,2.DOI:10.3969/j.issn.1674-4659.2024.07.0857
依达拉奉右莰醇治疗急性缺血性脑卒中患者的临床效果观察
Observation on Clinical Effect of Edaravone Dexborneol in the Treatment of Patients with Acute Ischemic Stroke
端木艳丽 1吕建华 1马娜2
作者信息
- 1. 濮阳市人民医院 药学部,河南濮阳 457000
- 2. 濮阳市人民医院 神经内科,河南濮阳 457000
- 折叠
摘要
Abstract
Objective To explore the clinical effect of edaravone dexborneol in the treatment of patients with acute ischemic stroke(AIS).Methods 98 AIS patients were randomly divided into study group(49 cases)and reference group(49 cases).The reference group received routine treatment,while the study group was treated with edaravone dexborneol on the basis of the reference group.The treatment effect,neurological function,serological indicators and incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the study group was 93.88%,higher than 79.59%in the reference group(P<0.05).After treatment,the NIHSS score,serum CRP and NSE levels of the study group were lower than those of the reference group(P<0.05).No statistical difference was found in the incidence of adverse reactions between the two groups(P>0.05).Conclusions Edaravone dexborneol in the treatment of AIS patients has significant effect,can significantly promote the recovery of neurological function,and improve the serum CRP and NSE levels,which is safe and reliable,and worthy of clinical promotion.关键词
急性缺血性脑卒中/依达拉奉右莰醇/NIHSS评分/血清学指标/不良反应Key words
Acute ischemic stroke/Edaravone dexborneol/NIHSS score/Serological indicator/Adverse reaction分类
医药卫生引用本文复制引用
端木艳丽,吕建华,马娜..依达拉奉右莰醇治疗急性缺血性脑卒中患者的临床效果观察[J].临床医学工程,2024,31(7):857-858,2.
